Methylation silencing of angiopoietin-like 4 in rat and human mammary carcinomas

Cancer Science

Volumn 102, Issue 7, 2011, Pages 1337-1343

  Hattori, Naoko ^a   Okochi Takada, Eriko ^a   Kikuyama, Mizuho ^a   Wakabayashi, Mika ^a   Yamashita, Satoshi ^a   Ushijima, Toshikazu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 5 AZA 2' DEOXYCYTIDINE; TRICHOSTATIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT;

ANGIOPOIETINS; ANIMALS; AZACITIDINE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; GENE SILENCING; HYDROXAMIC ACIDS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY;

EID: 79959264059     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01955.x     Document Type: Article

References (42)

1. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007; 8: 286-98.
2. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128: 683-92.
3. Linhart HG, Lin H, Yamada Y et al. Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev 2007; 21: 3110-22.
4. Hinshelwood RA, Clark SJ. Breast cancer epigenetics: normal human mammary epithelial cells as a model system. J Mol Med 2008; 86: 1315-28.
5. Yan PS, Venkataramu C, Ibrahim A et al. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res 2006; 12: 6626-36.
6. Cheng AS, Culhane AC, Chan MW et al. Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res 2008; 68: 1786-96.
7. Weng YI, Hsu PY, Liyanarachchi S et al. Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. Toxicol Appl Pharmacol 2010; 248: 111-21.
8. Ghoshal A, Preisegger KH, Takayama S et al. Induction of mammary tumors in female Sprague-Dawley rats by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine and effect of dietary fat. Carcinogenesis 1994; 15: 2429-33.
9. Snyderwine EG, Thorgeirsson UP, Venugopal M et al. Mammary gland carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine in Sprague-Dawley rats on high- and low-fat diets. Nutr Cancer 1998; 31: 160-7.
10. Russo J, Tay LK, Ciocca DR et al. Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis. Environ Health Perspect 1983; 49: 185-99.
11. Sukumar S, McKenzie K, Chen Y. Animal models for breast cancer. Mutat Res 1995; 333: 37-44.
12. Imaoka T, Nishimura M, Iizuka D et al. Radiation-induced mammary carcinogenesis in rodent models: what's different from chemical carcinogenesis? J Radiat Res (Tokyo) 2009; 50: 281-93.
13. Russo J, Russo IH. Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia 2000; 5: 187-200.
14. Suzuki H, Gabrielson E, Chen W et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002; 31: 141-9.
15. Okochi E, Watanabe N, Sugimura T et al. Single nucleotide instability: a wide involvement in human and rat mammary carcinogenesis? Mutat Res 2002; 507: 101-11.
16. Kuramoto T, Morimura K, Yamashita S et al. Etiology-specific gene expression profiles in rat mammary carcinomas. Cancer Res 2002; 62: 3592-7.
17. Okochi E, Watanabe N, Shimada Y et al. Preferential induction of guanine deletion at 5'-GGGA-3' in rat mammary glands by 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Carcinogenesis 1999; 20: 1933-8.
18. Watanabe N, Okochi E, Hirayama Y et al. Single nucleotide instability without microsatellite instability in rat mammary carcinomas. Cancer Res 2001; 61: 2632-40.
19. Yamashita S, Hosoya K, Gyobu K et al. Development of a novel output value for quantitative assessment in methylated DNA immunoprecipitation-CpG island microarray analysis. DNA Res 2009; 16: 275-86.
20. Takeshima H, Yamashita S, Shimazu T et al. The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands. Genome Res 2009; 19: 1974-82.
21. Yuan GC, Liu YJ, Dion MF et al. Genome-scale identification of nucleosome positions in S. cerevisiae. Science 2005; 309: 626-30.
22. Yamashita S, Takahashi S, McDonell N et al. Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers. Cancer Res 2008; 68: 2112-21.
23. Niwa T, Tsukamoto T, Toyoda T et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res 2010; 70: 1430-40.
24. Weisinger G, Gavish M, Mazurika C et al. Transcription of actin, cyclophilin and glyceraldehyde phosphate dehydrogenase genes: tissue- and treatment-specificity. Biochim Biophys Acta 1999; 1446: 225-32.
25. Terada K, Okochi-Takada E, Akashi-Tanaka S et al. Association between frequent CpG island methylation and HER2 amplification in human breast cancers. Carcinogenesis 2009; 30: 466-71.
26. Mandard S, Zandbergen F, van Straten E et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 2006; 281: 934-44.
27. Le Jan S, Amy C, Cazes A et al. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol 2003; 162: 1521-8.
28. Kaneda A, Kaminishi M, Yanagihara K et al. Identification of silencing of nine genes in human gastric cancers. Cancer Res 2002; 62: 6645-50.
29. Nobeyama Y, Okochi-Takada E, Furuta J et al. Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas. Int J Cancer 2007; 121: 301-7.
30. Padua D, Zhang XH, Wang Q et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 2008; 133: 66-77.
31. Foreman JE, Sharma AK, Amin S et al. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line. Cancer Lett 2009; 288: 219-25.
32. Girroir EE, Hollingshead HE, Billin AN et al. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines. Toxicology 2008; 243: 236-43.
33. Shibui T, Higo Y, Tsutsui TW et al. Changes in expression of imprinted genes following treatment of human cancer cell lines with non-mutagenic or mutagenic carcinogens. Int J Oncol 2008; 33: 351-60.
34. Taniura H, Kobayashi M, Yoshikawa K. Functional domains of necdin for protein-protein interaction, nuclear matrix targeting, and cell growth suppression. J Cell Biochem 2005; 94: 804-15.
35. Gong X, Kole L, Iskander K et al. NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53. Cancer Res 2007; 67: 5380-8.
36. Issa JP, Ahuja N, Toyota M et al. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001; 61: 3573-7.
37. Fatemi M, Pao MM, Jeong S et al. Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level. Nucleic Acids Res 2005; 33: e176.
38. Yamashita S, Tsujino Y, Moriguchi K et al. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci 2006; 97: 64-71.
39. Yamashita K, Upadhyay S, Osada M et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2002; 2: 485-95.
40. Wang H, Zhao Y, Li L et al. An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21Waf1/Cip1 in response to 5-aza-2'-deoxycytidine treatment. J Biol Chem 2008; 283: 2564-74.
41. Jacob HJ. Functional genomics and rat models. Genome Res 1999; 9: 1013-6.
42. Toyokuni S. Iron and carcinogenesis: from Fenton reaction to target genes. Redox Rep 2002; 7: 189-97.